Introduction {#sec1-1}
============

**What was known?**

Malignant melanoma, basal cell carcinoma and squamous cell carcinoma of skin are commonly associated with xeroderma pigmentosum, but the aggressive variant basaloid squamous carcinoma of skin in an 8-year-old child is a rare phenomenon.

Xeroderma pigmentosum (XP) is a rare autosomal recessive genodermatosis characterized by hypersensitivity to ultraviolet (UV) light affecting the cutaneous, ocular and nervous systems. It results due to a defect in the nucleotide excision repair mechanism. Nucleotide excision repair mechanism is responsible for deoxyribonucleic acid (DNA) repair following UV irradiation. Defect in these genes leads to build-up of unrepaired DNA damage which is responsible for a majority of the features of XP. There is a 1000-fold increased risk of development of cutaneous and 10 to 20-fold increased risk of developing non-cutaneous malignancies. XP is characterized by photosensitivity, pigmentary changes, photophobia, and propensity to develop malignancy in sun-exposed and ocular region.\[[@ref1][@ref2]\]

Case Report {#sec1-2}
===========

An 8-year-old child, known case of XP presented in our hospital according to parent\'s history with non-healing, rapidly growing ulcerative growth over the right eye of 4 month\'s duration. The patient had another raised lesion on right cheek skin for the same duration. There was history of photophobia and increased lacrimation of the left eye. The child\'s growth was retarded. There was no previous history of irradiation to the head and neck region. There was no history of trauma to the affected part. The child was born to non-consanguineous parents. On general examination the patient was frail and weak. The patient had dry atrophic skin with patchy hyper pigmentation all over the body presenting classical look of XP.

On local examination, the two lesions were different and distinctly apart. There was a 4 cm × 4 cm proliferative growth with areas of ulceration over the right lower eyelid occluding the eye completely \[[Figure 1](#F1){ref-type="fig"}\] and mobility of the growth was restricted. The ulcerated areas bled on touching. There was loss of vision in the right eye as a result of occlusion of right eye. The patient\'s opposite eye had conjunctival congestion and associated with scarring of the left cornea. There was another nodular lesion on the skin of right nasolabial fold of 1.5 cm × 1.5 cm with hyper pigmented areas and small area of ulceration \[[Figure 1](#F1){ref-type="fig"}\].

![An 8-year-old male child with xeroderma pigmentosum and growth over lower eyelid and nodular lesion on nasolabial fold](IJD-59-632d-g001){#F1}

Systemic neurological examination did not reveal any abnormality. Punch biopsies were taken from the ulceroproliferative growth over the right lower eyelid and ulcerated area over the nodular lesion.

Tissue sections from the growth over the lower eyelid revealed basaloid squamous cell carcinoma with feature of both basal and squamous cell carcinoma \[[Figure 2](#F2){ref-type="fig"}\]. Tissue sections from ulcerated area on nasolabial fold showed keratotic and mildly acanthotic epidermis with congested underlying tissue and no malignancy was seen. Based on histopathological examination report, the final diagnosis of basaloid squamous carcinoma of eyelid was confirmed.

![Photomicrograph (H and E, ×40) showing basaloid squamous carcinoma with peripheral palisading and adenoid cystic pattern](IJD-59-632d-g002){#F2}

The patient was planned for wide local excision of the malignant cutaneous lesion. However the parents of the child declined surgery and it was then planned for treatment with external beam radiotherapy. The patient received 30 Gy in ten fractions and response evaluated after completion of first phase of radiotherapy. There was no significant reduction of the lesion and also, there were associated adverse skin reactions like cutaneous infections and necrosis of skin. In view of serious adverse reactions and poor response to first phase of radiotherapy, further external beam radiotherapy was discontinued. The patient died within 6 months from the date of first diagnosis.

Discussion {#sec1-3}
==========

Prevalence of XPis 1 in 250,000.\[[@ref1]\] Basaloid squamous cell carcinoma of skin is a rare aggressive variant of squamous cell carcinoma, with a predilection for the head and neck region. The common cutaneous malignancies in patients with XP include squamous carcinoma, basal cell carcinoma, and malignant melanoma. XP with basaloid squamous cell carcinoma of skin is extremely rare and only few malignant epithelial skin cancers in children have been observed on the basis of predisposing genodermatosis.\[[@ref2]\] Basosquamous cell carcinoma of skin is seen mostly in males and in the age group of 47-81 years (mean age: 68. 6 years).\[[@ref3]\] However, very rarely basosquamous carcinoma of skin in children with XP has been mentioned in literature.\[[@ref4]\] Our patient is an 8-year-old child with dermal basaloid squamous cell carcinoma and XP. High degree of suspicion is required in patients with XP for early diagnosis of associated cutaneous malignancy in the pediatric population. Due to lack of clinical suspicion of malignancy, the diagnosis was delayed and patient presented with an advanced dermal basaloid squamous cell carcinomain head and neck region. Screening procedure has been recommended in patients with genodermatosis for cutaneous malignancy and leading to early intervention.\[[@ref5]\] There are no specific gross morphological features on clinical examination to distinguish basaloid squamous carcinoma and basosquamous carcinoma from squamous cell carcinoma and basal cell carcinoma of skin, respectively. The diagnosis can only be made after histopathological examination. In the early days, basosquamous carcinoma was considered to be a transition between basal cell carcinoma and squamous cell carcinoma. Contributions from immunohistochemical studies have suggested that it is a continuum of basal cell carcinoma and squamous cell carcinoma, where basal cell carcinoma undergoes squamous differentiation leading to development of basosquamous cell carcinoma.\[[@ref6][@ref7]\] This differentiation not only alters the histologic appearance but also the biologic behavior of basosquamous carcinoma compared to that of squamous cell carcinoma with basaloid differentiation.

In the present case, external beam radiotherapy was given as an effective therapeutic alternative treatment as advocated by Ben *et al*.\[[@ref8]\] The patients with XP do not have normal DNA repair mechanism, as a result of which patient may develop extreme sensitivity to radiation resulting in radiotherapy related complications. Sensitivity to radiation at the clinical as well as cellular level has been demonstrated in XP patients.\[[@ref9]\] In the present case, the tumor was radio insensitive and the patient developed radiation induced adverse effects of skin in presence of XP.

There is no accepted system for defining high risk patients with cutaneous squamous cell carcinoma. Prognosis of cutaneous squamous cell carcinoma depends upon location of tumor, like arising in previously injured skin (burns, trauma, etc.) have an increased risk of metastasis\[[@ref10][@ref11]\] with overall 5 year survival of 52%.\[[@ref12]\] In our case there was no previous history of trauma to the affected part. Tumor characteristics like tumor diameter, depth, extension into subcutaneous tissue, and poor differentiated histology have an elevated risk of recurrence, metastasis, and death;\[[@ref13]\] especially involvement of named nerve or diameter more than 0.1 mm.\[[@ref14]\] Fixity of tumor is a predictor of poor prognosis for dermal basaloid squamous cell carcinoma.

**What is new?**

In patients with xeroderma pigmentosum, high degree of suspicion should be raised with appearance of new skin lesions even in pediatric age groups. Early diagnosis with better prognostic indicators and wide local excision of lesions will be beneficial. Determining the degree of radio sensitivity is important in this syndrome as radiotherapy results in serious adverse reactions of skin.
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